Aclaris Therapeutics Announces Phase 2 Clinical Trial of ATI-501 Oral in Patients with Alopecia Areata Met Primary Endpoint

World News: . []

WAYNE Pa July 30 2019 GLOBE NEWSWIRE -- Aclaris Therapeutics Inc LINK  ACRS a physician-led biopharmaceutical company focused on immuno-inflammatory and dermatological LINK  today announced results from its Phase 2 LINK  trial of ATI-...

More news and information about Aclaris Therapeutics, Inc.

Published By:

Globe Newswire: 21:01 GMT Tuesday 30th July 2019

Published: .

Search for other references to "aclaris" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us